Clients use these reports when presenting their projects to potential funding and partnering groups. In addition, venture group clients find these reports helpful when performing due diligence on potential new investment opportunities. Areas we often address include:
- Review of therapeutic areas and evaluation of key players
- Identification of key compounds in discovery and development
- Identification of initial hits (from HTS or literature)
- Design of strategies for hit explosion and lead optimization
- Identification of primary and secondary screening assays
- Identification of relevant animal efficacy models
- Identification of milestones and decision points.